Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Maytansinoid-conjugated humanised monoclonal antibody against CD56

EU orphan designation number: EU/3/10/792
Active ingredient: Maytansinoid-conjugated humanised monoclonal antibody against CD56
Indication: Treatment of small cell lung cancer
Sponsor: ImmunoGen Europe Limited
c/o Reeves LLC, 24 Chiswell Street, Third Floor, London EC1Y 4YX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Centralised Orphan - Designation EMA/OD/056/10 (2010)6937 of 01/10/2010
25/07/2012 Other procedure EMA/OD/056/10
30/07/2014 Centralised Orphan - Removal of orphan designation from Community Register